New York, New York (PRWEB) April 16, 2013
The Conference Forum announced the 4th Annual Global Clinical Trials conference will take place on September 18, 2013 at the Fairmont Copley Plaza in Boston, MA.
Led by industry veteran Dr Christopher Gallen, CEO, of the Korean-based life science company, SK BioPharmaceuticals, the 2013 program places special emphases on how to reduce the complexities of global clinical trials.
Brand new this year is a section on Lessons Learned from Unsuccessful Global Clinical Trials led by Dr. Debra Barker, Chief Scientific Officer, Emerging Markets, Novartis.
“We are really pleased with the outpouring of interest from senior-level executives wanting to be part of the speaking faculty to help the industry with global clinical challenges, Valerie Bowling, Executive Director of The Conference Forum.
The Global Clinical Trials event received a wonderful response from the industry to be part of the event due to the latest industry developments and advancements as well as the events history. The extensive speaking faculty includes Dr. Mitchell Katz, Executive Director, Medical Research Operations, Purdue Pharma; Dr. Marielle Cohard-Radice, Vice President, Clinical Development Operations, Daiichi Sankyo Pharma Development; Jodie Morrison, CEO, Tokai Pharmaceuticals; and Ross Pettit, Vice President, Clinical Operations, AMAG Pharmaceuticals.
Exciting new and hot topics addressed include Re-thinking the Patient Experience; Designing Patient-Centric Protocols to Increase Global Patient Engagement and Reducing Protocol Complexity; and an Update on Risk Based Monitoring.
One of the best-rated and most popular sections of the conference is the regional roundtables, where experts with experience from all over the world (including China, India, Japan, Latin America and the EU) answer one-on-one questions, covering such topics as how to work globally with different regulatory agencies and patient recruitment, enrollment and engagement.
There will be many opportunities for networking, with special breaks, a breakfast and a luncheon. The conference has been described by attendees as having a congenial and friendly atmosphere with fostered communication between speakers and attendees as well as being knowledgeable and interesting, interactive and provocative.
Full program details are available at http://www.theconferenceforum.org.
AbbVie, AMAG Pharmaceuticals, Bristol-Myers Squibb, Celgene, Daiichi Sankyo, Endo Pharmaceuticals, EnVivo Pharmaceuticals, Genzyme, JANSSEN Alzheimer Immunotherapy, Merck, The Michael J. Fox Foundation for Parkinsons Research, Millennium: The Takeda Oncology Company, Novartis, Purdue Pharma, SK Bio-Pharmaceuticals, Target Health, Teva Pharmaceuticals, Tokai Pharmaceuticals, United Therapeutics
About The Conference Forum
The Conference Forum develops specialized public and private events and organizes research groups and advisory boards for professionals in the life science industry. The company currently offers conferences for R&D leaders, clinical development professionals, young and established biotech executives, drug delivery professionals and the investment community. Their mission is to create the best content in an ideal forum for the exchange of ideas among peers and networking for pharmaceutical and biotech professionals.